Patent Law Outline
Prof Golden
2012
Subject Matter
· any product or process
· includes Man-made living organisms, but non-human.
· Includes business methods. Eg, Amazon one-click.
· Software is okay if it produces TANGIBLE RESULT:
· State Street: transforming data to stock price is “tangible”
· This basically makes ALL software patentable.
· Improvements or new uses.
· But not:
· Laws of nature: gravity
· Abstract ideas: pure math formulas.
· Products of nature
· But purified product okay.
· illegal stuff. Eg, marijuana.
Utility
· Utility != better than prior art. Just:
· Not trivial
· Not mischievous or bad for society.
· But deceptive invention okay. Morality changes with time.
· In chemicals:
· Requires specific benefit from currently available form.
· Not enough if chemical requires further scientific testing
· Policy: do not discourage others from testing.
Anticipation
Novelty
· 102 (a), (e), (g) is the guts of the US first-to-invent system.
· Always concerns situation where someone OTHER THAN the inventor does something before the inventor’s INVENTION DATE.
· Every element was disclosed in a SINGLE prior art reference
· Inherency – if a property is NECESSARILY TRUE, prior art doesn’t need to disclose that.
· Eg, patent app for alloy that is “anti-corrosive” reads on prior publication of the alloy, even if the prior art doesn’t mention it is “anti-corrosive”, b/c it is an inherent property.
· Prior disclosure of SPECIES anticipates later claim of GENUS.
· Eg, if you claim mammals, a cow is a anticipating reference.
· Eg, patent app for alloy “up to 10% iron” reads on prior art that doesn’t mention iron (0%).
· But, GENUS prior art can also anticipate a SPECIES claim.
· If genus is representative of species.
· But not if species if somehow SPECIAL in the genus.
· Special property, or
· Same property but to a surprising degree
· For chemicals look at:
· Degree of structural similarities in genus
· Similar properties in genus
· How many parameters may be changed?
· Predictability of new properties in species?
· Is genus of physical mixtures or chemical compounds? Species in chemical compound genuses are more special.
· 102(a)
· Can’t patent if, prior to invention date, someone else:
· Knew or used in this country
· Published or patented anywhere in the world.
· Prior knowledge
· Fully disclosed:
· Eg, enabling document
· Eg, reduced
· Eg, a speech
· Cg, internal memos, classified gov reports, abandoned patent apps.
· Knowledge must be publicly accessible.
· Eg, a drawing on a table clothe is not considered publicly accessible.
· Must be in this country
· Prior use
· Reduced
· Used for intended purpose.
· Use was accessible to public, cannot be secret
· Public use can be “non-informing.” Ie, does not reveal how it works.
· Printed Publication
· Must be enabling
· Must be printed. But generally, saving in any form is enough.
· Must be published. But generally, publicly accessible is enough.
· Eg, one copy of paper at library, properly indexed is published.
· Eg, few copies circulated a small conference is published.
· 102(e)
· Before X invented, there was an unpublished (secret) pending patent app in the PTO.
· Patent app is treated like a publication, effective on its filing date.
· But patent app must ultimately issue a patent.
· 102(g)
· Before patentee’s invention, “invention” by another who hasn’t abandon, conceal or suppressed the invention.
· “invention” = conception + reduction.
· First to reduce usually wins.
· However, for someone who was second to reduce but first to conceive, he wins if he can show diligence from other inventor’s conception to his own reduction.
· If a date range is given, the last date in the range is used.
· Conception
· Forming a definite, enabling (no undue experimentation) idea.
· In court, conception must be corroborated by some physical evidence.
· Reduction: 3 requirements.
· Reduced invention is SAME as what is claimed.
· Reduc
:
· Confidential relationship: Eg, wife, supplier.
· Confidentiality agreements
· Use of secret method to produce products that are publicly sold
· Definition of “public use” changes depending actor:
· If use is by patentee, it is barring. Gore.
· If use is by 3rd party, it does not bar the patentee.
· However, if one can easily guess the process from the products sold or through reverse engineering, this is barring public use.
· Policy: encourage disclosure from patentee, but punishes 3P for exploitation without disclosure.
On-Sale Bar
· Commercial offer for sale
· Must give offeree power to accept
· Sale between two entities that are TOO CLOSE is not a sale.
· Experimental sale is not a sale.
· Sale of “patent rights”, eg, right to use, is not a sale. Must be sale of invention itself.
· Offer must be for CLAIMED invention
· Sale of MACHINE embodying method does not bar later patenting of METHOD; And sale of a SERVICE does not later bar patenting of MACHINE.
· But sometimes with the sale of a machine, the method was CONTEMPLATED by the buyer. Ie, it was part of the sale. Then that sale bars the method too.
· Eg, A car, with power steering. Buyer bargained for power steering.
· Invention must be “ready for patenting” at time of sale.
· Actually reduced to practice, or
· But remember, reduction means inventor must appreciate usefulness of invention.
· Policy: Can’t let people get around the on-sale bar by purposely not determining drug’s structure, if substance is known to be useful
· sufficiently specific description/drawing to enable skilled person to practice.
· Eg, drawings of chips considered concrete enough to be sold (Pfaff)